14/02/2005 (Agence Europe) - At a press conference held on 10 February in Paris, EuropaBio, France Biotech, Entreprises des medicaments (the French Pharmaceutical Industry Association) and the International Research Laboratories (LIR) presented a study which highlights the contribution of biotechnologies in the treatment of various diseases: diabetes, haemophilia, hepatitis B and C, multiple sclerosis, cancer and rheumatoid arthritis. (The report is available online at: www.bioimpact.org).